Virginia Prescription Injuries
Millions of Americans, including thousands of patients across Virginia, take prescription drugs to aid in the treatment of various medical conditions such as arthritis, severe pain, high cholesterol, mental disorders and heart problems. When consumers are directed by their physicians to use a specific pharmaceutical product, they trust that the medication will improve their condition.
Unfortunately, many of the drugs that are hitting the market are being released without adequate testing. Prescription drug injury cases have been making news recently as the result of recalls and warnings over serious health risks and side effects, including heart attacks, stroke, seizures, mental confusion, and suicidal thoughts or behavior.
Fortunately, drug manufactures can be held accountable for their actions. Through aggressive litigation, consumers in VA who have been harmed by prescription drugs can receive the compensation they deserve. Manufacturers of such drugs as Bextra, Vioxx, Celebrex, and Accutane have gone to court, and victims have received compensation in class-action lawsuits.
In addition to representing the direct victims of these devastating injuries, many Virginia prescription injury lawyers also represent the families of wrongful death victims who have died as a result of taking dangerous drugs.
If you or someone you love has been harmed by a prescription drug or product, please let your voice be heard. Raising awareness about the dangers and risks of pharmaceutical products can help save thousands of others from harm. A VA prescription drug injury attorney can advise you on what actions you need to take. Do not hesitate to call today; most consultations are free.
Contact a Mesothelioma attorney today to discuss your case:
FDA News Headlines
FDA Clears biospace med's SterEOS 2D/3D Workstation For Pediatric Use In Spine (Medical News Today)
ImmunoGen, Inc. Announces Orphan Drug Designation Granted To IMGN901 For Treatment Of Merkel Cell Carcinoma By US FDA ... (Medical News Today)
ETEX Corporation Announces FDA Clearance and Launch of Carrigen(R) Porous Bone Substitute Material (redOrbit)
InterMune Shares Jump On FDA Panel Recommendation (Fox News)
InterMune Shares Halted Pending FDA Review (Fox News)
FDA Clears The Fenwal Amicus(R) Separator System For Collecting Platelets In New Additive Solution (Medical News Today)
ThermalTherapeutic Systems Announces FDA Clearance Of The VERATHERM(TM) Portable Hyperthermic Perfusion System (Medical News Today)
Morinaga Milk Industry Co., Ltd. Receives No Objection Letter from FDA Regarding GRAS Status of Proprietary Probiotic ... (Business Wire via Yahoo! Finance)
ImmunoGen receives FDA orphan drug designation for IMGN901 compound in treatment of MCC (News-Medical-Net)
NicOx: FDA Panels Meet May 12 On Arthritis Drug (Fox News)
